Anatara Lifesciences Ltd (ASX:ANR)
Australia
· Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
At close: Apr 27, 2026
Anatara Lifesciences Revenue
Anatara Lifesciences had revenue of 177.56K AUD in the half year ending December 31, 2025, a decrease of -34.90%. This brings the company's revenue in the last twelve months to 623.76K, down -30.27% year-over-year. In the fiscal year ending June 30, 2025, Anatara Lifesciences had annual revenue of 969.46K with 50.53% growth.
Revenue (ttm)
623.76K
Revenue Growth
-30.27%
P/S Ratio
4.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Acrux | 2.81M |
| Nexalis Therapeutics | 986.43K |
| Zelira Therapeutics | 656.00 |
| Chimeric Therapeutics | 9.75M |
| Vectus Biosystems | 89.96K |
| Invex Therapeutics | 229.08K |
| Biotron | -868.00 |
| Tissue Repair | 3.38M |